Jacobs Levy Equity Management Inc. Has $3.53 Million Position in Dolby Laboratories $DLB

Key Points

• Jacobs Levy Equity Management Inc. increased its stake in Dolby Laboratories by 359.8%, owning 43,923 shares valued at approximately $3.53 million following the addition of 34,370 shares.
• Recent analyst ratings for Dolby have been generally positive, with a consensus rating of "Moderate Buy" and an average target price of $95.75, reflecting increasing confidence in the company's stock.
• Dolby Laboratories reported $0.78 EPS for the last quarter, surpassing estimates, and has set guidance for FY 2025 EPS between 3.880-4.030, indicating expected growth.

Jacobs Levy Equity Management Inc. increased its position in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 359.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 43,923 shares of the electronics maker's stock after purchasing an additional 34,370 shares during the period. Jacobs Levy Equity Management Inc.'s holdings in Dolby Laboratories were worth $3,527,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC boosted its position in Dolby Laboratories by 63.6% in the 1st quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker's stock valued at $90,946,000 after buying an additional 444,718 shares during the period. Advisors Asset Management Inc. lifted its position in Dolby Laboratories by 6.4% during the first quarter. Advisors Asset Management Inc. now owns 4,830 shares of the electronics maker's stock valued at $388,000 after acquiring an additional 291 shares during the last quarter. EP Wealth Advisors LLC purchased a new stake in Dolby Laboratories during the first quarter valued at approximately $379,000. Focus Partners Advisor Solutions LLC purchased a new stake in Dolby Laboratories during the first quarter valued at approximately $271,000. Finally, Royal Bank of Canada raised its holdings in shares of Dolby Laboratories by 3.5% in the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker's stock worth $5,491,000 after buying an additional 2,298 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Tigress Financial raised their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research report on Friday, August 15th. Robert W. Baird began coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 price target on the stock. Rosenblatt Securities restated a "buy" rating and set a $95.00 price target on shares of Dolby Laboratories in a research report on Friday, August 1st. Finally, Barrington Research restated an "outperform" rating and set a $100.00 price target on shares of Dolby Laboratories in a research report on Friday. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $95.75.

Dolby Laboratories Stock Down 0.9%

Shares of NYSE DLB traded down $0.63 during midday trading on Friday, hitting $71.48. The company had a trading volume of 337,864 shares, compared to its average volume of 440,754. Dolby Laboratories has a twelve month low of $68.24 and a twelve month high of $89.66. The business has a 50-day simple moving average of $73.73 and a two-hundred day simple moving average of $75.53. The firm has a market capitalization of $6.85 billion, a price-to-earnings ratio of 26.18 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The company had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities analysts forecast that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were paid a $0.33 dividend. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. Dolby Laboratories's dividend payout ratio is 48.35%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This represents a 9.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Yeaman sold 39,875 shares of the stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares in the company, valued at $8,583,724.50. This trade represents a 25.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 99,366 shares of company stock valued at $7,352,963 over the last 90 days. Insiders own 38.39% of the company's stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.